logo
Sign In
  1. Home
  2. Search
FiltersReset Filters
8 results

  • beleodaq

    (Belinostat)
    Medication Details
    Acrotech Biopharma Inc
    Usage: Beleodaq is indicated for treating adult patients with relapsed or refractory peripheral T-cell lymphoma (PTCL). Approval is based on tumor response rates and duration, but improvement in survival or symptoms has not been established. Continued approval may depend on further clinical benefit verification.
    Medication Details
    Drug Interactions

  • difamilast

    (Adquey)
    Medication Details
    Acrotech Biopharma Inc
    Medication Details
    Drug Interactions

  • evomela - melphalan injection, powder, lyophilized, for solution

    (Melphalan)
    Medication Details
    Acrotech Biopharma Inc
    Medication Details

  • folotyn

    (pralatrexate)
    Medication Details
    Acrotech Biopharma Inc
    Usage: FOLOTYN is indicated for treating patients with relapsed or refractory peripheral T-cell lymphoma (PTCL). Its approval is based on overall response rates, with continued approval dependent on confirmation of clinical benefits in future trials.
    Medication Details
    Drug Interactions

  • hemady - dexamethasone tablet

    (Dexamethasone)
    Medication Details
    Acrotech Biopharma Inc
    Medication Details

  • khapzory - levoleucovorin injection, powder, lyophilized, for solution

    (Levoleucovorin)
    Medication Details
    Acrotech Biopharma Inc
    Medication Details
    Drug Interactions

  • ryzneuta - efbemalenograstim alfa - vuxw injection

    (Efbemalenograstim Alfa-Vuxw)
    Medication Details
    Acrotech Biopharma Inc
    Medication Details

  • zevalin

    (ibritumomab tiuxetan)
    Medication Details
    Acrotech Biopharma Inc
    Usage: Zevalin is indicated for adult patients with relapsed or refractory low-grade or follicular B-cell non-Hodgkin's lymphoma (NHL) and for those with previously untreated follicular NHL who have responded to first-line chemotherapy.
    Medication Details
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
PrescriberPoint
HIPAA Logo
HIPAA COMPLIANT
SOC 2 Logo
Soc 2 Type II
PrescriberPoint
HIPAA Logo
HIPAA COMPLIANT
SOC 2 Logo
Soc 2 Type II
For ProvidersRequest DemoJoin Research Panel
Prescribing toolsPrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutCareersContact UsSecurity
Get the latest insights in your inbox
  • Terms and Conditions
  • Privacy Policy
  • © 2026 PrescriberPoint. All Rights Reserved.